Vimta Labs Ltd

Vimta Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vimta Labs Ltd

₹ 523 -1.77%
03 May - close price
vimta.com BSE: 524394 NSE : VIMTALABS
About

Vimta Labs Limited is testing food and drugs. It also does contract research for clinical research and pre-clinical studies provider in India. It provides analytical, clinical and preclinical services to life sciences industries; quality and safety testing for food and beverage industries; and environment services to a wide spectrum of industries. [1][2]

Key Points

Services
The company deals in drug life cycle management, development and discovery support services, clinical research, central lab, and cGMP analytical services for pharmaceutical and biopharmaceutical companies.
It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters & regulators, and EMI/EMC testing for electronic and electrical products. [1]

Website BSE NSE
  • Market Cap ₹ 1,160 Cr.
  • Current Price ₹ 523
  • High / Low ₹ 623 / 365
  • Stock P/E 28.0
  • Book Value ₹ 134
  • Dividend Yield 0.38 %
  • ROCE 24.6 %
  • ROE 18.6 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
59 60 61 76 67 74 79 80 77 82 83 73 82
42 43 45 56 47 51 55 54 56 58 59 58 60
Operating Profit 17 17 17 20 21 23 24 25 21 24 25 16 22
OPM % 28% 28% 27% 26% 31% 31% 30% 32% 28% 30% 30% 22% 27%
0 0 0 -1 1 0 1 1 1 1 1 2 1
Interest 1 1 0 0 0 1 1 1 1 0 0 1 1
Depreciation 6 6 6 6 6 7 7 8 8 8 8 9 9
Profit before tax 11 10 11 13 15 16 17 18 14 17 16 8 14
Tax % 24% 26% 26% 25% 25% 27% 28% 26% 27% 23% 25% 25% 25%
8 8 8 10 12 12 12 13 10 13 12 6 10
EPS in Rs 3.65 3.50 3.65 4.41 5.28 5.35 5.45 5.98 4.63 5.73 5.51 2.86 4.57
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
181 211 278 318 320
151 158 198 223 234
Operating Profit 30 53 80 95 87
OPM % 17% 25% 29% 30% 27%
3 1 0 3 4
Interest 4 2 2 3 2
Depreciation 21 23 23 31 34
Profit before tax 8 29 56 65 55
Tax % 17% 25% 26% 26%
7 21 41 48 41
EPS in Rs 3.10 9.68 18.69 21.77 18.67
Dividend Payout % 0% 21% 11% 9%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 21%
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 92%
TTM: -13%
Stock Price CAGR
10 Years: 16%
5 Years: 24%
3 Years: 30%
1 Year: 37%
Return on Equity
10 Years: %
5 Years: %
3 Years: 17%
Last Year: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 4 4 4 4 4
Reserves 168 190 230 277 292
33 30 19 15 19
40 50 54 65 61
Total Liabilities 246 274 307 362 377
138 135 169 175 180
CWIP 2 17 0 12 27
Investments 0 0 0 0 0
106 122 138 175 170
Total Assets 246 274 307 362 377

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
24 37 59 88
-21 -32 -38 -57
-1 -5 -17 -11
Net Cash Flow 3 1 5 20

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 117 127 101 92
Inventory Days 191 140 115 187
Days Payable 117 142 82 119
Cash Conversion Cycle 191 125 134 159
Working Capital Days 100 114 94 82
ROCE % 14% 24% 25%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
37.46% 37.46% 37.46% 37.46% 37.46% 37.46% 37.26% 37.25% 37.23% 37.00% 36.98% 36.92%
0.00% 0.00% 0.19% 0.36% 0.35% 0.49% 2.28% 2.25% 2.72% 2.74% 2.88% 5.13%
0.11% 1.40% 1.91% 1.96% 2.01% 2.04% 2.13% 2.14% 2.14% 1.50% 1.49% 1.50%
62.43% 61.14% 60.44% 60.22% 60.18% 60.02% 58.35% 58.37% 57.92% 58.75% 58.65% 56.45%
No. of Shareholders 20,92819,94719,19418,33218,10618,28318,91617,16217,43918,42919,95718,550

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls